|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Net income (loss) from continued operations | |||
| Adjustments to reconcile consolidated net income (loss) to net cash | |||
| Income tax expense (benefit) | |||
| Financial result | |||
| Depreciation and amortization | |||
| Net loss (gain) from the disposal of intangibles and PP&E | |||
| Reversal of impairments of financial assets, net | |||
| Other non-cash (income) expenses | |||
| Change in equity method investments (non-cash) | |||
| Change in non-current financial assets (non-cash) | |||
| Listing expense | |||
| Non-cash effects | |||
| Working capital adjustments: | |||
| Changes in trade and other receivables | |||
| Changes in inventories | |||
| Change in trade and related party payables | |||
| Change in provisions | |||
| Taxes received (paid), net | |||
| Cash provided by (used in) operating activities | |||
| Purchases of intangible assets and property, plant and equipment | |||
| Receipts from sale and leasback transaction | |||
| Receipts from sale and leaseback transaction | |||
| Investments in financial assets | |||
| Proceeds from sale (purchases) of financial assets, net | |||
| Payment for loan to shareholder | |||
| Proceeds from disposal of a subsidiary | |||
| Interest received | |||
| Cash used in (provided by) investing activities | |||
| Proceeds from debt financing | |||
| Payments for debt financing | |||
| Proceeds from business combination | |||
| Payment of lease liabilities | |||
| Interest paid | |||
| Decrease in restricted cash | |||
| Change in restricted cash | |||
| Transaction with minority shareholder | |||
| Cash (used in) provided by financing activities | |||
| Net increase (decrease) in cash and cash equivalents | |||
| Effect of foreign exchange rate changes on cash and cash equivalents | |||
| Cash and cash equivalents at the beginning of the period | |||
| Cash and cash equivalents at the end of the period |
Loading...
